Sandra REGINAL

Sandra Reginal possesses a diverse background in microbiology and bioinformatics, with notable experience in molecular diagnostics and infrastructure administration. At APHM, Sandra served as a team leader focused on COVID-19 molecular diagnostics, leading RTq-PCR testing and training technicians while managing laboratory operations within a BSL2 environment. Presently, Sandra works as an Infrastructure Administrator at Capgemini. Previous roles include developing proteolytic activity characterization methods for Lactobacillus spp. at Soredab and researching antisense RNA for triple-negative breast cancer treatment at CRCM. Sandra holds a Bachelor's degree in Cellular Biology and multiple Master's degrees, including in Microbiology and System and Network Administration.